COPIA Magnificent

Company Overview

Snapshot

Founded in October 2016, COPIA Magnificent operates with 1–10 employees. The company has raised $750,000 across one funding round from one investor. In March 2025, COPIA Magnificent ceased to operate.

Business overview

COPIA Magnificent develops a method to inhibit biofilm formation, which is a significant issue in the dairy, food, and beverage industries, as well as on processing equipment. The company's core technology involves adding a healthy food-grade compound to milk, which not only reduces and inhibits biofilm formation but also reportedly increases cheese production by 5% to 10%. COPIA Magnificent operates in the Agriculture & Food Technologies sector, specifically targeting food processing and food trade & services, with a focus on B2B business models and a global market reach.

Company Intelligence Q&A

What is COPIA Magnificent's primary focus?

COPIA Magnificent focuses on inhibiting biofilm formation in dairy products and other food-related applications. Their method uses a food-grade compound to reduce bacterial communities that can contaminate milk, beverages, and processing equipment.

When was COPIA Magnificent founded?

COPIA Magnificent was founded in October 2016.

What is the status of COPIA Magnificent?

COPIA Magnificent ceased to operate in March 2025.

What was the total capital raised by COPIA Magnificent?

COPIA Magnificent raised a total of $750,000.

What is the core technology developed by COPIA Magnificent?

COPIA Magnificent developed a method that involves adding a healthy food-grade compound to milk. This compound is designed to reduce and inhibit biofilm formation, and it is also reported to increase cheese production by 5% to 10%.